Skip to main content
OpenTrials
Completed

NCT Number: NCT05069883

Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

It was a randomized controlled trial conducted at department of Urology, Armed Forces Institute of Urology, Rawalpindi from 1st January, 2018 July 2019 to 31st March 2021 to determine the role of oral steroids after Direct Vision Internal Urethrotomy to reduce the recurrence rate of urethral strictures.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Recurrence Disease Attributes Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

20 year–60 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Armed Force Institute of Urology

Rawalpindi, Punjab Province, 54000, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with urethral stricture with restricted urine flow of < 15 ml/min on uroflowmetry

Exclusion criteria

  • Patients presenting with post-anastomotic urethroplasty strictures (assessed on history and medical record),
  • Patients with post-TURP strictures
  • Patients with neurogenic bladder
  • Patients with prior history of steroid use
  • Patients with extravasation during optical internal urethrotomy

Treatment and study plan

Steroid Drug

Drug

In this group Oral steroid medication after Direct Vision Internal Urethrotomy

Other names: Oral steroid medication

No steroid

Drug

In this group no Oral steroid medication (palcebo medication) after Direct Vision Internal Urethrotomy

Other names: Placebo Medication

Primary outcomes

  1. Recurrence of Urethral Stricture

    Time frame: 6 months post-operatively

    Number of patients presenting with recurrence of urethral stricture after direct vision internal urethrotomy

Sponsors and collaborators

Lead sponsor

Services Hospital, Lahore

Other Gov

Collaborators

  • Armed Forces Institute of Urology, Rawalpindi

Registry information

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Oct 6, 2021
Registry last updated
Oct 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.